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Altered physiological states require neuronal adapta-
tion. In late pregnancy and lactation, a sub-popula-
tion of the mouse hypothalamic tuberoinfundibular
dopaminergic (TIDA) neurons alters their behavior
to synthesize and release met-enkephalin rather
than dopamine. These neurons normally release
dopamine to inhibit prolactin secretion and are acti-
vated by prolactin in a short-loop feedback manner.
In lactation, dopamine synthesis is suppressed in
an opioid-dependent (naloxone-reversible) manner,
meaning that prolactin secretion is disinhibited. Con-
ditional deletion of the prolactin receptor in neurons
reveals that this change in phenotype appears to
be driven by prolactin itself, apparently through an
alteration in intracellular signaling downstream of
the prolactin receptor that favors enkephalin produc-
tion instead of dopamine. Thus, prolactin effectively
facilitates its own secretion, which is essential for
lactation and maternal behavior. These studies pro-
vide evidence of a physiologically important, revers-
ible alteration in the behavior of a specific population
of hypothalamic neurons in the adult brain.
INTRODUCTION
The anterior pituitary hormone, prolactin, mediates a wide range
of physiological functions in addition to its archetypal lacto-
tropic actions on the mammary gland (Bernichtein et al., 2010;
Grattan, 2015; Grattan and Kokay, 2008). Within the brain,
many of prolactin’s actions facilitate maternal adaptation to
pregnancy and behaviors conducive to the successful rearing
of young (Brunton et al., 2008; Grattan and Kokay, 2008; Larsen
and Grattan, 2012). In contrast to other pituitary hormones,Cell Re
This is an open access article under the CC BY-Nendogenous prolactin secretion is high and predominately regu-
lated by inhibitory tone from the hypothalamus, with disinhibi-
tion being a predominant mode of facilitating secretion. The
anterior pituitary lactotrophs spontaneously release prolactin,
which is tonically inhibited by dopamine secreted within the
median eminence from the terminals of tuberoinfundibular
dopaminergic (TIDA) neurons. In males and non-pregnant fe-
males, low circulating levels of prolactin are maintained by a
‘‘short-loop’’ negative feedback, in which prolactin directly in-
teracts with the TIDA neurons to increase their firing rate and
thus dopamine output (Brown et al., 2012, 2016; Freeman
et al., 2000; Grattan et al., 2008; Lyons et al., 2012; Romano`
et al., 2013).
During late pregnancy and lactation, circulating prolactin
levels rise to support lactation and enable maternal behavioral
adaptations (Arbogast and Voogt, 1996; Brisken et al., 1999;
Grattan et al., 2008). For this to occur, the dopamine-mediated
inhibitory tone upon the lactotrophs must be alleviated, despite
the ongoing presence of elevated prolactin levels (and during
late pregnancy, placental lactogen) in the circulation. A number
of studies have suggested that the TIDA neurons become ‘‘re-
fractory’’ to prolactin-mediated negative feedback during this
time. For example, central administration of prolactin to non-
pregnant female rats increases activity of tyrosine hydroxylase
(TH), the rate-limiting step in dopamine synthesis, in the median
eminence in non-pregnant rats but has no effect during lactation
(Arbogast and Voogt, 1996; Demarest et al., 1983). Similarly,
despite elevated prolactin levels during lactation, the rat arcuate
nucleus shows reduced levels of both THmRNA and TH protein,
with an associated reduction in dopamine turnover and secretion
at themedian eminence (Andrews, 2005; Szabo´ et al., 2011). This
downregulation of prolactin-induced dopamine synthesis and
secretion during lactation does not arise from a reduction in pro-
lactin receptor expression, with in situ hybridization revealing
similar levels of prolactin receptor mRNA in the arcuate nucleus
of non-pregnant and lactating rats and mice (Augustine et al.,
2003; Brown et al., 2011; Kokay and Grattan, 2005). Mostports 26, 1787–1799, February 12, 2019 ª 2019 The Authors. 1787
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
strikingly, we have shown that prolactin-induced electrophysio-
logical responses in TIDA neurons are unaltered between non-
pregnant and lactatingmice, although they now fail to synthesize
and release dopamine (Romano` et al., 2013).
Intriguing observations made almost 25 years ago indicated
that the opioid peptide enkephalin was expressed in the TIDA
neurons during lactation (Ciofi et al., 1993; Merchenthaler,
1994). Because dopamine production is lost during this state,
TIDA neurons may switch their phenotype from dopaminergic
to enkephalinergic during lactation. Given that these neurons
remain electrophysiologically responsive to prolactin during
lactation (Romano` et al., 2013), it seems likely that enkephalin
rather than dopamine may be the neurochemical output from
these neurons at this time. Such a switch in output would be
expected to have significant physiological consequences for
the regulation of prolactin secretion during lactation.
The aim of this study was to test the hypothesis that prolactin
feedback is responsible for the neurotransmitter switch in the
TIDA neurons during late pregnancy and lactation. We also
investigated the hypothesis that the transition from a dopami-
nergic to enkephalinergic phenotype involves an alteration in
signal transduction pathways downstream of the prolactin re-
ceptor. Finally, we have investigated whether prolactin stimu-
lates enkephalin release from the median eminence in the
lactating mouse and the consequences of such action in terms
of pituitary function. Together, the data suggest a profound
change in the hypothalamic regulation of prolactin secretion
during lactation, promoting a state of hyperprolactinemia.
Essentially during this time, the short-loop negative feedback
regulation of prolactin secretion switches to a condition where
elevated prolactin facilitates its further secretion. Similar mecha-
nisms may occur in other neuronal populations that undergo
plasticity over lifespan in adults.
RESULTS
Met-Enkephalin Expression in the Arcuate Nucleus of
the Mouse Is Increased during Lactation
There was no change in the number of TH-immunoreactive cells
within the arcuate nucleus during late pregnancy and lactation
(Figures 1A–1D). The level of ThmRNA expression in the arcuate
nucleus was however markedly affected (F [2,22] = 5.72; p <
0.01; one-way ANOVA) such that it was significantly reduced
during both late pregnancy and lactation compared to diestrus
controls (p < 0.05; Tukey’s multiple comparison test; Figure 1E).
There was also a change in proenkephalin (Penk) mRNA expres-
sion during this time (F [2,22] = 18.25; p < 0.0001; one-way
ANOVA), with its level increased during both late pregnancy
and lactation compared to diestrus animals (p < 0.0001 and
p < 0.05, respectively; Tukey’s multiple comparison test;
Figure 1J). The number of met-enkephalin immunoreactivity
cells within the arcuate nucleus also increased during this time
(F [2,11] = 17.57; p < 0.001; one-way ANOVA), being significantly
greater during late pregnancy (p < 0.001) and lactation (p <
0.001) compared to diestrus controls (Tukey’s multiple compar-
ison test; Figures 1F–1I). The lactation-associated rise in met-
enkephalin-expressing cell number was specific to the arcuate
nucleus, with no significant change in met-enkephalin expres-1788 Cell Reports 26, 1787–1799, February 12, 2019sion in the paraventricular nucleus and a significant decline in
the dorsomedial hypothalamus (Figure S1).
During Lactation, the Majority of Met-Enkephalin-
Expressing Cells in the Arcuate Nucleus Are Also
Immunoreactive for Tyrosine Hydroxylase
In the dorsomedial arcuate nucleus, the primary location of the
TIDA neurons (Freeman et al., 2000), the number of cells that
were dual labeled for TH and met-enkephalin increased mark-
edly during lactation (Figures 1K–1P). In diestrus animals, less
than 10% of the met-enkephalin immunoreactive cells also ex-
pressed TH, whereas during lactation, this number had risen to
about 80% (p < 0.005; Student’s t test; Figure 1Q). It should be
noted, however, that, even during lactation, although the number
of dual-labeled cells was significantly increased (p < 0.005; Stu-
dent’s t test), they constituted only approximately one-third of all
TH-positive neurons present in this region (34.8% ± 3.8%;
Figure 1R).
The Lactation-Induced Increase in Met-Enkephalin and
PenkmRNA Expression in TIDA Neurons Is Mediated by
Prolactin
Alteration of prolactin levels significantly affected the number
of met-enkephalin cells in the dorsomedial arcuate nucleus
(F [3,16] = 23.84; p < 0.0001; one-way ANOVA; Figures 2A–2E).
As expected, lactation increased the number of met-enkephalin
immunoreactive cells compared to diestrus (p < 0.0005; Tukey’s
multiple comparison test; Figures 2A, 2C, and 2E). Suppressing
prolactin levels in lactating mice with bromocriptine from 355.6 ±
62.7 ng/mL to 45.3 ± 9.1 ng/mL (compared to 18.2 ± 6.0 ng/mL
during diestrus) significantly reduced the number of these cells
(p < 0.01; Tukey’s multiple comparison test) to approximately
half that seen in untreated lactating animals (Figure 2B and 2E;
22.2 ± 2.1 cells per section in lactating animals falling to 10.9 ±
2.6 cells per section following treatment with bromocriptine).
Furthermore, maintaining serum prolactin levels in bromocrip-
tine-treated lactating mice with ovine prolactin (245.8 ±
69.1 ng/mL) prevented this decrease in number of met-enkeph-
alin-expressing cells such that it was similar to that seen during
lactation (30.4 ± 2.1 cells per section; Figures 2D and 2E). In situ
hybridization revealed that the number of cells in the arcuate nu-
cleus expressing Penk mRNA during lactation increased more
than 10-fold compared to diestrus animals (1.6 ± 0.5 to 20.2 ±
2.0 cells per section; Figures 2F–2H). Similarly, the number of
cells expressing PenkmRNA, which was low in lactating animals
24 h after pup withdrawal, was significantly increased when the
circulating concentration of prolactin was increased to greater
than 100 ng/mL by osmotic pump infusion of exogenous prolac-
tin (2.7 ± 1.2 to 11.8 ± 4.2 cells per section; Figures 2I–2K).
The Lactation-Induced Increase in Met-Enkephalin and
Penk mRNA Expression in the TIDA Neurons Is
Dependent on a Neuronal Prolactin Receptor
The observations above suggest that prolactin acts on TIDA neu-
rons during late pregnancy or lactation to promote met-enkeph-
alin expression. This concept was confirmed by data obtained
from PRLRlox/lox/CamK-Cre mice, which lack prolactin receptors
in forebrain neurons, including TIDA neurons (Brown et al., 2016).
Figure 1. Met-Enkephalin Expression in Tyrosine-Hydroxylase-Positive Neurons within the Arcuate Nucleus Is Increased during Lactation
(A–J) Representative images of arcuate nucleus sections showing tyrosine hydroxylase (TH) (A–C) and met-enkephalin (F–H) immunoreactive cells in diestrus
(A and F), late pregnant (B and G), and lactating (C and H) mice. Quantification of the number of TH and met-enkephalin immunoreactive cells is shown in (D) and
(I), respectively, and is presented as the mean ± SEM per section (data analyzed by one-way ANOVA followed by Tukey’s multiple comparison test; n = 4 or 5). Th
and Penk mRNA expression in the arcuate nucleus is shown in (E) and (J), respectively, with levels in late pregnancy and lactation presented relative to those
found during diestrus (data analyzed by one-way ANOVA followed by a Tukey’s multiple comparison test; n = 6–11).
(K–P) Representative confocal images of dorsomedial arcuate nucleus sections showing TH (green), met-enkephalin (red) immunoreactive cells, and merged
images of diestrus (K–M) and lactating (N–P) mice. Filled arrowheads indicate TH immunoreactive cell bodies co-labeled with met-enkephalin, and open
arrowheads indicate either TH or met-enkephalin immunoreactive cell bodies, which are not dual labeled.
(Q) The percentage of met-enkephalin immunoreactive cells that were also stained for TH in the dorsomedial arcuate nucleus.
(R) The percentage TH immunoreactive cells in the same region that were also stained for met-enkephalin.
Data represent themean ± SEM (n = 3mice), and statistical analysis was performed using an unpaired Student’s t test. 3V, third ventricle. Scale bars: (A–C and F–
H) 100 mm and (K–P) 30 mm. *p < 0.05, ***p < 0.005, ****p < 0.001, and *****p < 0.0001.Despite being hyperprolactinemic, due to the lack of prolactin
feedback on TIDA neurons, these animals could become preg-
nant but often failed to nurse their pups (Brown et al., 2016).Hence, all investigations were conducted on day 18 of preg-
nancy. Both reproductive (F [1,17] = 9.03; p < 0.01; two-way
ANOVA) and genetic (F [1,17] = 12.84; p < 0.005; two-wayCell Reports 26, 1787–1799, February 12, 2019 1789
Figure 2. The Lactation-Induced Increase in Met-Enkephalin and Penk mRNA Expression in TIDA Neurons Is Mediated by Prolactin
(A–D) Representative images of met-enkephalin immunoreactivity in the dorsomedial arcuate nucleus of diestrus (A), lactating (C), and bromocriptine-treated
lactating mice with (D) or without (B) ovine prolactin replacement.
(E) Quantitation of the number of met-enkephalin immunoreactive cells per section under each condition. Data represent the mean ±SEM, and statistical analysis
was conducted using one-way ANOVA followed by a Tukey’s multiple comparison test (n = 4–7).
(F–H) PenkmRNA expression in diestrus (F) and lactating (G) mice. Quantitation of the number of Penk-mRNA-positive cells per section under each condition is
presented in (H). Data represent the mean ± SEM, and statistical analysis was performed using an unpaired Student’s t test (n = 4–6 mice).
(I–K) Penk mRNA in lactating animals that have undergone pup-withdrawal with (J) or without (I) prolactin replacement (high prolactin defined as >100 ng/mL).
Quantitation of the number of Penk-mRNA-positive cells per section under each condition is presented in (K).
Data represent the mean ± SEM, and statistical analysis was conducted using one-way ANOVA followed by a Tukey’s multiple comparison test (n = 4–7).
Br, bromocriptine; Prl, ovine prolactin; 3V, third ventricle. Scale bars: 50 mm. *p < 0.05, **p < 0.01, ****p < 0.0005, and *****p < 0.0001.
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ANOVA) status significantly influenced the number of met-
enkephalin-positive cells in the arcuate nucleus, with a signifi-
cant interaction between the two factors (F [1,17] = 13.9; p <
0.005; two-way ANOVA; Figures 3A–3E). In contrast to age-
matched PRLRlox/lox Cre-negative controls, the prolactin recep-
tor-deleted animals showed no increase in arcuate nucleus
met-enkephalin immunoreactivity in late pregnancy, with the
number of met-enkephalin immunoreactive cells remaining
unchanged from those in the non-pregnant state (3.9 ± 0.8
and 4.6 ± 2.1 cells per section, respectively; Figures 3C–3E).
As can be seen in Figures 3F–3J, deletion of the neuronal prolac-
tin receptor had an essentially identical effect on Penk mRNA
expression in the arcuate nucleus with the rise in the number
of Penk-mRNA-positive cells during late pregnancy being
abolished in animals lacking the neuronal prolactin receptor
(F [1,19] = 109.1; p < 0.0001; two-way ANOVA; Figure 3J).
Prolactin-Receptor-Mediated Signaling in the TIDA
Neurons Is Altered during Lactation
If, as our data suggest, prolactin stimulation of TIDA neurons
can drive met-enkephalin expression during late pregnancy
and lactation but drives dopamine synthesis and secretion at
other times, this may indicate a pregnancy-induced change
to the signal-transduction pathways mediating prolactin action
in the TIDA neurons. Prolactin receptor stimulation activates
both the signal transducer and activator of transcription 5
(STAT5) and extracellular-signal-regulated 1/2 (ERK1/2) path-
ways. Immunohistochemistry revealed that reproductive status
has a significant effect on the number of TH-immunoreactive
cells expressing activated (tyrosine phosphorylated) STAT5
(pSTAT5) (F [2,15] = 98.82; p < 0.0001; two-way ANOVA) and
that this was significantly influenced by experimental manipula-
tion of prolactin levels (F [2,15] = 12.47; p < 0.001; two-way
ANOVA). During diestrus, slightly less than half (46.8% ±
7.9%) of the TH immunoreactive cells in the dorsomedial
arcuate displayed nuclear pSTAT5 labeling (Figures 4A and
4G). As expected, due to the elevated circulating prolactin in
lactating mice, this number significantly increased to 81.6% ±
4.0% (p < 0.01; Tukey’s multiple comparisons test; Figures 4D
and 4G). Suppression of prolactin secretion with bromocriptine
essentially abolished pSTAT5 immunoreactivity in both diestrus
and lactating animals (Figures 4B, 4E, and 4G). Acute adminis-
tration of exogenous prolactin to bromocriptine-treated animals
resulted in a significant, and similar, increase in the number of
TH-pSTAT5 dual-labeled cells in both diestrus and lactating
animals (p < 0.0001; Tukey’s multiple comparisons test in both
cases) compared to that seen following bromocriptine treatment
(Figures 4C, 4F, and 4G). The data in Figure 4 also show that
reproductive status alters the number of TH-immunoreactive
cells expressing phosphorylated ERK1/2 (pERK1/2) (F [2,19] =
13.45; p < 0.0003; two-way ANOVA) and that this was signifi-
cantly influenced by experimental manipulation of prolactin
levels (F [2,19] = 26.29; p < 0.0001; two-way ANOVA). During
diestrus, a lower percentage of TH-immunoreactive cells were
dual labeled for pERK1/2 compared to those expressing
pSTAT5 (compare Figure 4G with 4N). The number of pERK1/
2-stained TH cells increased markedly in lactation, rising
approximately four-fold from 4.8% ± 0.5% in diestrus to21.6% ± 4.5% in lactation (p < 0.01; Tukey’s multiple compari-
sons test; Figures 4H, 4K, and 4N). Bromocriptine treatment did
not affect pERK1/2 expression in diestrus animals but abolished
the lactation-associated rise (Figures 4I, 4L, and 4N). Although
acute treatment with exogenous prolactin to bromocriptine-
treated animals stimulated an almost 10-fold increase in the
number of TH-positive cells also expressing pERK1/2 in diestrus
mice (p < 0.001; Tukey’s multiple comparisons test; Figures 4J
and 4N), it was without a significant effect on lactating animals
(Figures 4M and 4N). The effect of acute prolactin treatment
on bromocriptine-treated animals was also investigated using
western blot analysis of arcuate nucleus micro-punch samples.
In agreement with the immunohistochemical data described
above, western blot analysis confirmed that acute prolactin
treatment (20 min) increased pSTAT5 levels in both diestrus
and lactating mice, but the pERK1 and pERK2 responses
were lost in the latter (Figure S2).
Prolactin Stimulates the Release of Met-Enkephalin
from the Median Eminence of the Lactating Mouse,
which May Reduce the Activity of Tyrosine Hydroxylase
Met-enkephalin expression in TIDA neurons during late preg-
nancy and lactation may lead to its release at the median
eminence. To examine this possibility, brain slices at the level
of the arcuate nucleus from lactating mice were exposed to
saline or prolactin for 30 min and then fixed and dual stained
for met-enkephalin and TH. Under basal conditions, strong
met-enkephalin immunoreactivity was closely associated with
the TH-expressing external zone of the median eminence (Fig-
ure 5A, left panels). After prolactin application, the intensity of
the TH staining remained unchanged, whereas met-enkephalin
immunoreactivity was significantly reduced compared to that
seen in slices treated with saline alone (Figures 5A and 5B).
Because these data suggest that prolactin may stimulate met-
enkephalin release from nerve terminals in the median eminence
of lactating mice, we investigated two possible physiological
targets for this opioid peptide: first, the TIDA neurons them-
selves, and second, the anterior pituitary lactotrophs. In the
former experiments, pregnant mice were treated with the opioid
receptor antagonist, naloxone, from late gestation to day 10 of
lactation. Western blot analysis of hypothalamic tissue from
these animals showed a significant increase in the level of acti-
vated TH (as indicated by its phosphorylation on serine-40)
compared to that seen in lactating animals treated with saline
only (Figure 5C; p < 0.05; Student’s t test). These data are consis-
tent with a tonic opioid-mediated inhibition of TH phosphoryla-
tion in the TIDA neurons during lactation, which would effectively
reduce the activity of this enzyme and thus suppress the produc-
tion of dopamine.
Met-Enkephalin Increases Ca2+ Signaling and Prolactin
Secretion from Pituitary Lactotrophs of Lactating Mice
To determine the effect of met-enkephalin on the lactotrophs,
pituitary slices from prolactin-DsRed animals (He et al., 2011;
Hodson et al., 2012) were loaded with the Ca2+ indicator
Fura-2 and the Ca2+ responses measured. In approximately
one-third of the cells, a 15-min treatment with met-enkephalin
(500 nM) induced a strong increase in the Ca2+-spiking activityCell Reports 26, 1787–1799, February 12, 2019 1791
Figure 3. The Lactation-Induced Increase in Met-Enkephalin and PenkmRNA Expression in the TIDA Neurons Is Dependent on a Neuronal
Prolactin Receptor
(A–D) Representative images of met-enkephalin immunoreactivity in the arcuate nucleus of PRLRlox/lox (A) and PRLRlox/lox/CamK-Cre (C) non-pregnant mice, and
PRLRlox/lox (B) and PRLRlox/lox/CamK-Cre (D) late-pregnant mice.
(F–I) Representative images of PenkmRNA expression in the arcuate nucleus of PRLRlox/lox (F) and PRLRlox/lox/CamK-Cre (H) non-pregnant mice, and PRLRlox/lox
(G) and PRLRlox/lox/CamK-Cre (I) late pregnant mice.
Quantitation of the number of met-enkephalin immunoreactive and Penk-expressing cells per section under each of the above conditions is shown in (E) and (J),
respectively. Data represent the mean ± SEM, and statistical analysis was performed using two-way ANOVA followed by a Tukey’s multiple comparison test, n =
4–6. Grey columns, diestrus; pink columns, lactating. Scale bars: 75 mm. ****p < 0.0005 and *****p < 0.0001.of the lactotroph population (n = 327/957 responsive lacto-
trophs in 7 slices from 3 animals; Figures 6A–6C). Analysis of
the frequency domain using short-time Fourier transform
confirmed the presence of increased power at higher frequency
ranges during the application of met-enkephalin, indicating a
statistically significant effect of treatment on lactotroph Ca2+-
spiking activity (Figures 6D and 6E). To determine whether1792 Cell Reports 26, 1787–1799, February 12, 2019this corresponded to an increase in lactotroph output, hemi-
pituitary explants from lactating animals were incubated for
10 min with met-enkephalin (500 nM) followed by measurement
of prolactin concentrations in the medium by ELISA. Met-
enkephalin induced a moderate but significant increase in
prolactin secretion compared to controls (Figure 6F; p < 0.05;
n = 4–6 pituitaries).
Figure 4. Prolactin-Receptor-Mediated Signaling in the TIDA Neurons Is Altered during Lactation
(A–F) Representative images of the dorsomedial arcuate nucleus showing TH (brown cytoplasmic staining) and pSTAT5 (black nuclear staining) immunoreactivity
in diestrus and lactatingmice. Diestrus animals (A) received bromocriptine pre-treatment with (C) or without (B) acute (20min) prolactin injection. Matched images
(legend continued on next page)
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Figure 5. Prolactin Stimulates the Release of
Met-Enkephalin from the Median Eminence
of the Lactating Mouse, which May Reduce
the Activity of Tyrosine Hydroxylase
(A) Representative images of the median eminence
from lactating mice, showing prolactin-induced
secretion of met-enkephalin. The intensity of TH
immunoreactivity (red) was not affected by a
30-min incubation with prolactin (upper images),
whereas met-enkephalin immunoreactivity (green)
was reduced (lower images).
(B) Quantification of the met-enkephalin immuno-
reactivity in themedian eminence (normalized for TH
immunoreactivity) with or without prolactin (PRL)
stimulation. Data represent the mean ± SEM (*p <
0.05; unpairedStudent’s t test; n = 5 from3animals).
(C) Representative western blot and quantitation of
serine-40 phosphorylated TH (pTH) and b-actin
content in the median eminence and arcuate
nucleus of control (Ctrl) and naloxone-treated
(Nalo) lactating mice (10 mg/kg).
Data represent the mean ± SEM (*p < 0.05; un-
paired Student’s t test; n = 4 controls, 5 naloxone).
Scale bar: 50 mm.DISCUSSION
Physiological hyperprolactinemia is essential for successful
lactation, because it establishes milk production and facilitates
adaptation of maternal physiology and behavior (Grattan et al.,
2008; Grattan and Le Tissier, 2015). Elevation of circulating pro-
lactin concentration is achieved, at least in part, by a relaxation of
the negative-feedback pathway by which prolactin suppresses
its own secretion through promoting dopamine release from
the TIDA neurons. We have shown previously that, although
the TIDA neurons reduce dopamine synthesis and release during
lactation, they remain electrophysiologically responsive to pro-
lactin (Romano` et al., 2013). The physiological significance of
this persistent prolactin response in the absence of a dopami-
nergic output has been unknown. We report here that during
late pregnancy and lactation, a sub-population of TIDA neurons
undergoes a prolactin-dependent transition from a dopami-
nergic to enkephalinergic phenotype. Prolactin-induced stimula-
tion of met-enkephalin release from the TIDA neurons during
lactation may promote further prolactin secretion from the pitui-
tary, through either suppression of dopamine synthesis and
release or a direct stimulatory action on the lactotrophs. Thus,
a sub-population of the TIDA neurons appear to undergo a
phenotypic switch during late pregnancy and lactation, convert-
ing a dopaminergic short-loop negative feedback system intofrom lactating animals are presented in (D), (E), and (F), respectively. (i) and (ii) pr
single-labeled TH cells (white arrowheads) and dual-labeled TH/pSTAT5 cells (b
(G) The percentage of TH immunoreactive cells dual labeled with pSTAT5 under
(H–M) Representative epifluorescent images of the dorsomedial arcuate nucleus s
mice. Diestrus animals (H) received bromocriptine pre-treatment with (J) or witho
are presented in (K), (L), and (M), respectively.
(N) The percentage of TH immunoreactive cells dual labeled with pERK1/2 unde
All data represent the mean ± SEM, and statistical analysis was performed using
columns, diestrus; pink columns, lactating; scale bars represent 50 mm. In (G), ** i
0.001 compared to bromocriptine-treated diestrus animals.
1794 Cell Reports 26, 1787–1799, February 12, 2019one using met-enkephalin to induce a positive stimulus for pro-
lactin release. Such neurotransmitter switching is becoming
increasingly recognized as a form of neuronal plasticity (Spitzer,
2017). Our proposed model of TIDA neuron plasticity during late
pregnancy and lactation is summarized diagrammatically in
Figure 7.
Lactation was associated with a decrease in ThmRNA and an
increase in PenkmRNAwithin the arcuate nucleus. The observa-
tion that these changes were already present in late pregnancy
suggests they result from hormonal as well as suckling-induced
neuronal signaling to the TIDA neurons (Berghorn et al., 2001;
Szabo´ et al., 2011; Wang et al., 1993). The absence of a corre-
sponding reduction in the level of TH protein indicates the com-
plex nature of TH regulation (Kumer and Vrana, 1996) but is
consistent with previous findings showing that reduced dopa-
mine synthesis in this region results from lower levels of the acti-
vated TH (serine-40 phosphorylated) rather than total enzyme
(Romano` et al., 2013). Dual labeling for TH and met-enkephalin
immunoreactivity indicated that approximately one-third of the
dopaminergic neurons, presumed to be TIDA neurons, also
expressed met-enkephalin during lactation. Although this is a
marked rise from the situation in diestrus animals, it contrasts
with findings in the lactating rat, where almost all TIDA neurons
expressed enkephalin (Merchenthaler, 1994; Merchenthaler
et al., 1995). It should be noted, however, that, unlike the dataesent higher-magnification images of the boxed areas in (B) and (C), showing
lack arrowheads).
each of the six experimental conditions is presented.
howing TH (green) and pERK1/2 (red) immunoreactivity in diestrus and lactating
ut (I) acute (20 min) prolactin injection. Matched images from lactating animals
r each of the six conditions is presented.
two-way ANOVA followed by Tukey’s multiple comparison test (n = 3–6). Grey
ndicated p < 0.01, and in (N), **p < 0.01 compared diestrus controls and ***p <
Figure 6. Met-Enkephalin Increases Ca2+ Signaling and Prolactin Secretion from Pituitary Lactotrophs of Lactating Mice
(A) Representative image of Fura-2 fluorescence in an acute pituitary slice from PRL-DsRed mouse.
(B) Example traces for the 6 lactotrophs (circled in A) treated for 15 min with met-enkephalin (500 nM; indicated by the bar).
(C) 15 min treatment with met-enkephalin induced increased Ca2+ spiking in approximately one-third of the lactotrophs (n = 327/957 responsive lactotrophs
in 7 slices from 3 animals).
(D) Average STFT spectrogram for the Ca2+ recordings of cells responsive to Enk stimulation, showing an increase in FFT power throughout the frequency range
analysed during the Enk treatment (black bar).
(E) Average frequency spectrum (shown as average ± SEM) in the 15 min preceding (black line), during (light blue line) or after (dark blue line) Enk exposure
(***p < 0.0001, control versus Enk and wash versus Enk, mixed effect model).
(F) Met-enkephalin (500 nM for 15min) significantly increasedPRL secretion from hemi-pituitary explants compared to thosemaintained inmedia alone (*p < 0.05;
**p < 0.01; unpaired Student’s t test; n = 4–6 pituitaries). Open columns, saline treated; filled columns, enkephalin treated.reported here, the antibody used in these earlier studies does not
distinguish between met- and leu-enkephalin. Although the
actual percentage of dual-labeled cells may be influenced by
species or methodological differences, our current data are
consistent with growing recognition that the TIDA neurons may
not represent a homogeneous population. Arcuate dopamine
neurons have been found, for example, to exist in distinct groups
in terms of their electrophysiological characteristics (Liang and
Pan, 2011; Romano` et al., 2013; Zhang and van den Pol,
2015), expression of potential co-transmitters (Brown et al.,
2016), and catecholamine-synthesizing enzymes and trans-
porters (Battaglia et al., 1995; Ugrumov, 2009). Most strikingly,
recent studies using single-cell genetic profiling have identified
up to six subtypes of dopaminergic neurons in this region
(Campbell et al., 2017; Romanov et al., 2017). It is currently
unknown whether the met-enkephalin-expressing TIDA neurons
are coincident with one of these identified sub-populations, but
the observation that essentially all TH-immunoreactive nerve
terminals in the mouse median eminence also stained for
enkephalin during lactation (Ciofi et al., 1993) suggests they
may preferentially target the median eminence and thereby
represent true neuroendocrine neurons.The induction of met-enkephalin in the TIDA neurons was
driven by prolactin and was lost following pharmacological
suppression of prolactin during lactation or in the absence of
prolactin receptors in the brain. These observations are sup-
ported by previous findings in the rat that indicated that prolac-
tin can induce enkephalin expression in TIDA neurons during
lactation (Merchenthaler et al., 1995; Nahi and Arbogast,
2003). The fact that the changes were initiated during preg-
nancy suggests that placental lactogen is likely to be the major
factor acting through the prolactin receptor to mediate this
effect (see Figure 7). It should be noted that, although the D2
agonist bromocriptine was employed in these studies to sup-
press prolactin release from the pituitary, it may also target
other D2 receptors, including dopaminergic autoreceptors ex-
pressed on the TIDA neurons, which have been reported to
provide an ultrafast negative feedback (Stagkourakis et al.,
2016). The profile of Penk mRNA expression, determined by
in situ hybridization, paralleled the above immunohistological
observations, with the lactation-associated rise in number of
Penk-mRNA-positive cells within the arcuate nucleus being
reversed by prolactin depletion (following pup-withdrawal)
and partially restored by prolactin replacement. Similarly,Cell Reports 26, 1787–1799, February 12, 2019 1795
Figure 7. Diagrammatic Summary Depict-
ing the Lactation-Induced Change in the
TIDA Neuron Phenotype
During a non-lactating state, the TIDA neurons
respond to prolactin by releasing dopamine (DA)
(light blue arrow) into the portal blood at the me-
dian eminence (ME), which in turn inhibits prolactin
secretion from lactotrophs. Chronic exposure to
the prolactin agonist placental lactogen during
pregnancy results in an alteration in the prolactin
receptor signaling pathway, which supports met-
enkephalin (ENK, light green arrow) expression in a
subpopulation of the TIDA neurons. Suckling-
induced activation of these neurons results in the
release of the opioid, which acts on neighboring
TIDA neurons to suppress dopamine synthesis
(red arrows) and secretion at themedian eminence
(broken arrow), and directly on the lactotrophs,
increasing prolactin secretion. As a result of this
lactation-induced change in the TIDA neuron
phenotype, the original prolactin-mediated nega-
tive feedback loop has been effectively converted
to one of positive feedback.depletion of neuronal prolactin receptors also prevented a
lactational rise in the number of Penk-mRNA-expressing cells.
The ability of prolactin to switch fromdriving a dopaminergic to
an enkephalinergic output from the TIDA neurons during late
pregnancy and lactation may result from a modification to the
intracellular signaling profile activated by its receptor. The phys-
iological trigger for such a change is likely to arise from the
dramatic pregnancy-specific alteration in the pattern of prolactin
receptor activation occurring at this time, with high levels of
placental lactogen providing a prolonged, chronic stimulus as
distinct from the short-term, phasic patterns of prolactin secre-
tion seen in early pregnancy. Although prolactin receptors are
coupled to multiple intracellular signals, we focused on the
twomajor pathwaysmediated by pSTAT5 and pERK1/2, respec-
tively (Freeman et al., 2000). As expected, the elevation of endog-
enous prolactin during lactation significantly increased the
percentage of dopaminergic (TH-expressing) cells also labeled
with pSTAT5 or pERK1/2 compared to the levels seen in diestrus
animals when prolactin is low. Interestingly, if endogenous pro-
lactin levels were first suppressed with bromocriptine, diestrus
and lactating animals exhibited a similar pSTAT5 responsiveness
to the injection of exogenous prolactin, but the pERK1/2 signal
was lost in the latter group. This conclusion was supported by
parallel western blot analysis, which also showed preservation
of the prolactin-induced pSTAT5 response but loss of the
pERK signaling during lactation. This suggests that, although1796 Cell Reports 26, 1787–1799, February 12, 2019prolactin receptor coupling to the pSTAT5
pathway is unchanged between the two
physiological states, its ability to signal
via pERK1/2 has been markedly downre-
gulated in the lactating mice. It should
be noted that, although pSTAT5 is primar-
ily a transcription factor, pERK is a multi-
function protein kinase with both nuclear
and cytoplasmic targets. Although therole of a diminished pERK1/2 response in prolactin-mediated
met-enkephalin expression is unknown, it is consistent with a
reduction in the phosphorylation of TH and thus a fall in the dopa-
mine-synthesizing capacity of these neurons.
The proposal that TIDA neurons release enkephalin rather than
dopamine during lactation is supported by evidence that
increased opioid signaling may underlie lactational hyperprolac-
tinemia (Arita and Kimura, 1988; Chihara et al., 1978; Meltzer
et al., 1978; Rivier et al., 1977). Most notably, immunoneutraliza-
tion of endogenous opioids or the administration of naloxone (or
mu- or kappa-selective opioid receptor antagonists) suppresses
both the antepartum prolactin surge and suckling-induced pro-
lactin secretion in rats (Andrews and Grattan, 2002; Arbogast
and Voogt, 1998; Callahan et al., 2000). Furthermore, both mu
and kappa opioid receptor mRNA is expressed in the medial
basal hypothalamus (Tavakoli-Nezhad and Arbogast, 2010)
and lactation is associated with increased enkephalin immuno-
reactivity in the median eminence (Ciofi et al., 1993; Mer-
chenthaler, 1994). Although the physiological targets of secreted
opioid peptide have yet to be determined, close appositions be-
tween met-enkephalin fibers and dopaminergic neurons in the
median eminence and arcuate nucleus suggest a possible opioid
action on the TIDA neurons (Magoul et al., 1993, 1994; Mansour
et al., 1993; Zhang and van den Pol, 2015), a possibility sup-
ported by electrophysiological data that opioid receptor agonists
inhibit TIDA neuron activity (Zhang and van den Pol, 2015).
Similarly, in vivo and in vitro studies have shown that enkephalin
inhibits dopamine turnover in the median eminence (Arita and
Kimura, 1988; Ferland et al., 1977), an observation consistent
with the data presented here that naloxone increases the
serine-40 phosphorylation, and thus activity, of TH in the arcuate
nucleus of the lactating mouse. These results suggest that,
during late pregnancy and lactation, prolactin- or placental-lac-
togen-induced met-enkephalin released from TIDA neurons
may exert autocrine signaling to suppress dopamine output
and thus disinhibit the lactotrophs, allowing increased prolactin
release from the pituitary.
The data presented in Figure 6 suggest that prolactin may
stimulate met-enkephalin release from the median eminence,
from where it may potentially access and target the pituitary
lactotrophs. Although this interpretation of these immunohis-
tochemical data is consistent with our overall hypothesis, it is
important to stress that this approach does not directly measure
enkephalin release and should therefore be interpreted conser-
vatively. Further verification using a more direct quantitative
approach will be required to confirm this.
Such a proposal is, however, supported by the presence of
opioid receptors on a subset of anterior pituitary cells in the rat
(Carretero et al., 2004) and evidence that met-enkephalin either
promotes prolactin secretion (Carretero et al., 1992) or over-
comes its suppression by dopamine (Enjalbert et al., 1979).
Our current data extend these observations by showing that
met-enkephalin directly increases Ca2+ signaling in a sub-popu-
lation of lactotrophs in the intact mouse pituitary gland and that
this response is concurrent with increased prolactin secretion.
Thus, it is possible that met-enkephalin released by the TIDA
neurons during late pregnancy and lactation can directly
enhance the secretory activity of the lactotrophs.
Collectively, these data reveal a remarkable plasticity in TIDA
neurons during late pregnancy and lactation. We propose a
model whereby chronically elevated placental lactogen modifies
prolactin receptor signaling, leading to a reduction in ERK1/2-
mediated phosphorylation of TH and a concurrent activation of
met-enkephalin expression. The consequent reduction of dopa-
mine synthesis means that, in response to continued stimulation
by prolactin, these neurons alter their behavior and secrete met-
enkephalin instead of dopamine. The met-enkephalin acts via
opioid autoreceptors on the TIDA neurons, further suppressing
the activity of TH. It may also travel in the portal blood to the
pituitary, where it promotes prolactin secretion from the lacto-
trophs. These changes facilitate suckling-induced prolactin
secretion by allowing it to be maintained unopposed by a nega-
tive feedback and indeed potentially facilitated by positive feed-
back actions. This adaptive switch in TIDA neuron behavior
establishes a period of hyperprolactinemia that is only termi-
nated by the weaning of the pups.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Genetic mouse models
Generation of PRLRlox/lox/CamK-Cre mice
A conditional transgenic mouse was also used in which prolactin receptors had been deleted frommost forebrain neurons, including
TIDA neurons, by crossing homozygous female prolactin receptor flox mice (PRL-Rlox/lox) with heterozygous male CamKinase IIa
Cre-recombinase mice (Brown et al., 2016). In brief, the presence of the wild-type Prlr allele was detected by primer 1 (50-TGT
CCAGAC TACAAAACCAGTGGC-30) and primer 2 (50-CAG TGCTCTGGAGAGCTGGC-30), which span the Lox71 site subsequent
to exon 5 and amplify a 546 bp product from wild-type mice but not from Prlrlox/lox mice. Mice carrying a Prlr lox/lox allele were
identified using primer 1 and primer 3 (50-ACC TCC CCC TGA ACC TGA AAC ATA A-30). Primer 3 is located within the inverted
GFP sequence and thus only produces a 400 bp band from mice heterozygous or homozygous for the Prlr lox/lox allele, whereas
no band is generated fromwild-typemice. The presence or absence of CamK-Cre was determined using primers creP1 (50-GGT TCT
CCG TTT GCA CTC AGG-30), creP3 (50-CTG CAT GCA CGG GAC AGC TCT-30), and creP17 (50-GCT TGC AGG TAC AGG AGG TAG
T-30). CreP1 and creP3 span the start site of the endogenous CaMKIIa gene locus and produce a 285 bp band in wild-type animals
only. CreP17 anneals within the inserted cre sequence at the modified CaMKIIa-cre gene locus to generate a 380 bp product with
creP1, but only in mice with at least one copy of this Cre construct.
Generation of prolactin-DsRed mouse
Transgenic mice expressing DSRed under the control of the prolactin promoter were generated as previous described in He et al.
(2011) and Hodson et al. (2012).
Animal care and procedures
Animal procedures complied with the animal welfare guidelines of the European Community (Agreement 34.128) or the Animal Ethics
Committee of the University of Otago. Adult virgin female mice aged 8-12 weeks and weighing 20-25 g were obtained from the
University of Otago animal breeding facility, or for data presented in Figures 5 and 6, fromCharles River (France). Animals were group
housed under controlled temperature (22 ± 1C) and lighting (12 h light, 12 h dark cycle, lights on at 0600 h) conditions with ad libitum
access to food and water. Estrous cycles were monitored by daily cytological examination of vaginal smears with diestrous animals
used as non-pregnant controls. Late-pregnant micewere used on day 18 of pregnancy, the presence of vaginal plug indicating day 1,
and lactating mice were used between day 7 and 10 post-partum. In some experiments, endogenous prolactin secretion was
suppressed by three consecutive injections of bromocriptine mesylate (5 mg/kg sc every 12 h, Sigma-Aldrich). Some animals
were injected with ovine prolactin (10 mg/kg ip, Sigma-Aldrich) at the same time as the bromocriptine treatment. For investigation
of prolactin action on intracellular signaling pathways, mice were injected with saline or ovine prolactin (10 mg/kg ip) 20 min prior
to being perfused and processed for immunohistochemistry (see below). Immunohistochemical staining for met-enkephalin required
animals to be treated with 30 mg colchicine (Sigma-Aldrich; 1 mL icv injection at Bregma +0.75 mm lateral, 0.1 mm posterior
and +2.4 mm ventral) 24 h before perfusion. Serum levels of mouse prolactin were measured using radioimmunoassay as described
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Penk mRNA expression was investigated using lactating mice which were without pups for 24 h. Prolactin levels were maintained
in the absence of suckling by a subcutaneous osmotic minipump (1003D, AlzetTM) delivering ovine prolactin (1500 mg/d in 0.01 M
sodium bicarbonate buffer (pH 9.2); biopotency 20-50 IU, Sigma-Aldrich). Prolactin or vehicle (saline) filled pumps were implanted
on days 4 to 6 of lactation under isoflurane anesthesia and the animals left to recover for 24 h. The pups were then removed
and the dams left for a further 24 h before they were perfused with 2% PFA in 0.1 M phosphate buffer (pH 7.4). Atrial blood
samples obtained immediately prior to perfusion were used for the measurement of plasma ovine prolactin concentrations by
radioimmunoassay.
METHOD DETAILS
Immunohistochemistry
Animals were euthanized with 3 mg sodium pentobarbital, transcardially perfused with 4%paraformaldehyde and the brains excised
and post-fixed in the same fixative for at least 1 h before being cryoprotected with 30% sucrose in Tris-buffered saline (TBS) at 4C
overnight. Four sets of 30 mm sections from the level of paraventricular nucleus (Bregma 0.58 mm) to caudal arcuate nucleus
(Bregma 2.12 mm) were obtained. Immunostaining for either met-enkephalin or TH was achieved by incubating tissue sections,
in which endogenous peroxidase activity had been quenched (0.1% H2O2:40%methanol in TBS), overnight at 4
C with either rabbit
anti-methionine enkephalin (Immunostar, catalog #20065) or rabbit anti-TH (Millipore, catalog #AB151) diluted 1:1000 and 1:10000
respectively, in TBS containing 0.03% Triton-X, 0.25% bovine serum albumin and 2% normal goat serum. Sections were then
incubated for 90 min at room temperature with biotinylated goat anti-rabbit IgG (Invitrogen; diluted 1:500) and staining visualized
using biotin-avidin complex kit (Vector Laboratories) with nickel enhanced 3,30-diaminobenzidine (DAB) (Sigma-Aldrich). Immuno-
staining for pSTAT5 required antigen retrieval (5 min in 10 mM Tris-HCl, pH 10 at 90C followed by a further 5 min cooling at
room temperature) and three 10 min washings in TBS (Brown et al., 2010). Endogenous peroxidase activity was then quenched
as above and sections incubated for 72 h at 4C with rabbit anti-pSTAT5 (Tyr694) (Cell Signaling Technology catalog #9359; diluted
1:400) followed by nickel-enhanced DAB detection as above. Dual-labeling these sections for TH was achieved by repeating the
peroxidase quenching and then incubating overnight at 4Cwith rabbit anti-TH (diluted as above) followed by peroxidase-conjugated
goat anti-rabbit IgG (Vector Laboratories; diluted 1:200) and then DAB without nickel enhancement. Dual-labeling for TH with either
met-enkephalin or pERK1/2 required the use of fluorescently-conjugated anti-mouse secondary antibodies. To achieve low
background staining, endogenous mouse immunoglobulins were first blocked by incubating the sections overnight at 4C with an
AffiniPure Fab’ fragment of goat anti-mouse IgG (H+L) (Jackson ImmunoResearch Laboratories, catalog #15-007-003; diluted
1:100 in TBS), followed by a cocktail of mouse anti-TH (Millipore, catalog #MAB318, diluted 1:1000) with anti-met-enkephalin (as
above) or rabbit anti-phospho-pERK1/2, (Cell Signaling Technology, catalog #4370 diluted 1:1000) overnight at 4C. Staining was
visualized using the fluorescently-tagged secondary antibodies (Molecular Probes catalog #A11029 and #A11036, both diluted
1:1000). All DAB or fluorescently stained sections were mounted on gelatin-coated glass slides and coverslipped with DPX or Vecta-
shield mounting medium, respectively. Stained sections were viewed and photographed using an Olympus BX51 microscope.
Confocal images were captured using a Zeiss LSM 510 Meta upright confocal microscope with excitation at 488 nm and 543 nm
and a z-interval of 5 mm. A positive-labeled cell was counted if it had the nucleus present with at least one proximal process visible
and was of approximately 10-20 mm in diameter. Quantification was performed from 3-4 representative sections of dorsomedial
arcuate nucleus, an anatomical location of the TIDA population (Lyons et al., 2010; Zhang and van den Pol, 2015). In Figure 1, the
whole arcuate nucleus was analyzed to provide a more appropriate comparison to the qPCR data obtained from tissue punches.
Western blotting
For the data in Figure 5mice injected (ip) with naloxone (10mg/kg) or saline (day 10 of lactation) were killed by cervical dislocation and
the brains immediately excised and frozen on dry ice before being stored at 80C. Coronal sections (300 mm at approximately
Bregma1.46 to2.12mm)were cut on a cryostat andmicropunched samples of the arcuate nucleus, prepared as described above
but including themedian eminence, were transferred to 30 mL of 50mM Tris buffer containing 2mM ethylenediaminetetraacetic acid,
10 mM NaF, 2 mM NaP2O7, 2 mM Na2-glycerophosphate, 1 mM Na3VO4, 1 mM PMSF and 4% sodium lauryl sulfate. Protein
concentrations were determined using a Pierce BCA kit. b-mercaptoethanol (8% final) was then added to the samples, which
were heated to 100C. Protein samples (10 mg) were separated by 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and transferred to nitrocellulose membranes which were probed with antibodies against TH phosphorylated at Ser-40 (Zymed
Laboratories, catalog #368600) diluted 1:2000 in TBS containing 0.3% Triton-X (Romano` et al., 2013). b-actin labeling was used
as a loading control (Abcam, catalog #ab8226, diluted 1:12000). For the data presented in Figure S2 animals were treated with
bromocriptine mesylate (5mg/kg) followed by 20 min of ovine prolactin (10 mg/ kg). For detection of phospho-proteins, antibodies
against anti-pSTAT5 (Tyr694) (Cell Signaling Technology catalog #9359; diluted 1:1000) and anti-pERK1/2 (Cell Signaling Technology
catalog #4370; diluted 1:12000) both diluted in TBST containing 5% BSA were used. The respective non-phospho proteins were
detected with anti- STAT5a/b pan (R&D System catalog AF2168; diluted 1:1000) and anti-p44/42 MAPK (Cell Signaling Technology
catalog #4695; diluted 1:6000) diluted in 5% non-fat milk in TBST and were used to normalize the levels of phospho-proteins. Immu-
noreactive bands were visualized using enhanced chemiluminescence detection in accordance with the manufacturer’s instructions
and densitometric analysis performed using Quantity One 1-D Analysis Software (Bio-Rad).e3 Cell Reports 26, 1787–1799.e1–e5, February 12, 2019
Quantitative PCR
Quantitative PCR was used to determine the level of mRNA expression in tissue samples micropunched from the arcuate nucleus.
Mice were decapitated and their brains removed, frozen on dry-ice and stored at 80C. Under RNase-free conditions, 300 mm
coronal cryostat sections were prepared at approximately Bregma 1.34 to 2.30 mm and tissue punches collected from the
arcuate nucleus using a blunt-end needle. A single 500 mm diameter punch was obtained from each section centered on the midline
immediately superior to the median eminence. Punches from three consecutive sections were pooled in 350 mL of lysis buffer
(RNeasy Mini Kit, QIAGEN) containing 1% b-mercaptoethanol. Following sonication, RNA was extracted using RNeasy mini spin
columns (QIAGEN) and purity determined using a Nanodrop 2000 spectrophotometer (Life Technologies). All samples used in this
study had a 260/280 nm ratio of 2 or greater. RNA aliquots (35 ng) were reverse transcribed using SuperScript III reverse transcriptase
(Invitrogen) and stored at 20C until required. Oligonucleotide primers for the following transcripts were designed using ensemble.
org and Primer Blast.Penk (NM_001002927.2) forward: 50-TCCTGAGGCTTTGCACCTGG-30, reverse: 50-AGTGTGCAGCCAGGA
AAT TG-30); Th (NM_009377.1): forward: 50-GCCCCCAGAGATGCA AGTC-30 and reverse: 50-TGT TGGCTGACCGCACAT-30 and
b-actin (NM_007393.3), forward: 50-ATGGGGCCAGGAGAA ATC TA-30 and reverse: 50-GCC TGG ATG GCT ACG TAC ATC ATG-30
were used. SYBRgreen based qPCRwas performed in triplicate using an Applied Biosystems ViiA7 qPCR system (Life Technologies)
and the fold changes in mRNA levels determined by normalizing against b-actin mRNA using the DDCt method. Primer efficiencies
were confirmed to lie between 92 and 105%.
In situ hybridization for Penk mRNA
Animals were decapitated and coronal sections of 16 mm were obtained using a cryostat at 20C and immediately mounted onto
RNase free aminopropyltriethoxysilane (APS)-coatedmicroscope slides. Slidesmountedwith brain sectionswere thawed at 55C for
5 min before sections were fixed in 2% PFA (5 min). The slides were washed in 0.5 3 sodium chloride citrate buffer (SCC; 75 mM
sodium chloride, 7.5 mM sodium citrate, pH 7) prior to incubation in proteinase K (2 mg/ml and acetylation with 0.25% acetic
anhydride). The slides were washed in 23 SCC before being taken through graded ethanol incubations of increasing concentration
before incubation in chloroform for 5 min. Slides were air-dried for 3 h. Primers were designed for the mouse Penk gene using the
GenBank mRNA sequence (accession number NM 001002927.2). The sequences were:50-CTTTGCACCTGGCTGCTGGC-30(for-
ward) and 50-GGGAACTCGGGCCTGGACAC-30 (reverse). Reverse transcription polymerase chain reaction (PCR) was used to
generate a DNA template with sequences encoding the T7 and SP6 polymerase promoter sites incorporated onto the ends of the
primer sequences. 35S UTP-labeled RNA probes were transcribed from the cDNA template using a Riboprobe in vitro transcription
kit (Promega) and the appropriate polymerase (T7 for the antisense probe, SP6 for the sense probe). The probes were purified using
Mini Quick spin columns (Roche) to remove unincorporated nucleotides. Probes were denatured at 95C for 3 min (40 ng probe/slide
with 50 mg tRNA/slide). Sections were then covered with 100 ml hybridization buffer/probe mix (hybridization buffer: 100 mM dithio-
threitol, 0.3 M sodium chloride, 20mM Tris base (pH 8), 5 mMEDTA, 13Denhardt’s solution, 10% dextran sulfate, 50% formamide).
The slides were coverslipped and incubated overnight at 55C. Sections were washed, incubated with ribonuclease A (20 mg/ml) for
30min and thenwashed in 0.13SCC (with 10mM b-mercaptoethanol and 1mMEDTA) at 55C for 2 h. Sections were incubatedwith
anti-digoxigenin (DIG) antibody conjugated to alkaline phosphatase (1:2000) for 48 h. The DIG-labeled probeswere detected byNBT/
BCIP (nitroblue tetrazolium chloride/5-bromo-4 chloro-3-indolyl-phosphate) substrate. Color development was monitored under the
microscope. The reaction was terminated after 23 h by four 30 min washes in buffer (150 mM NaCl, 10 mM NaH2PO4, 1 mM EDTA).
Sections were dipped in ethanol, dried at 42C for 1 h, immersed in xylene and coverslipped with Vectamount mounting medium. No
staining was evident in sections incubated with the sense probe. Images were captured using an Olympus BX61 light microscope
fitted with a QImaging Micropublisher 5.0RTV camera (QImaging, Surrey, Canada). Quantification and analysis were performed
as described previously (Gustafson et al., 2017)
In vitro measurement of met-enkephalin and TH expression in the median eminence
Lactating mice (day 10 of lactation) were killed by rapid decapitation, following isoflurane anesthesia. The brain was quickly removed
and placed in ice-cold artificial cerebrospinal fluid (aCSF) containing 118 mM NaCl, 3 mM KCl, 11 mM D-glucose, 10 mM HEPES,
25 mM NaHCO3, 6 mM MgCl2 and 0.5 mM CaCl2, osmolarity between 295 and 305 mOsm, pH 7.2 when gassed with 5% CO2
and 95% O2. The brain was then glued to the stage of a vibratome and 150 mm thick coronal sections cut and incubated in aCSF
for 60 min at 37 in 5% CO2/95% O2. The medium was then replaced with another 500 mL of aCSF with or without ovine prolactin
(500 ng/ml) and incubated for a further 30 min and then the tissue immersion fixed in 4% paraformaldehyde overnight. The next
day, immunohistochemical detection of met-enkephalin and TH was performed, as described above. Slices were imaged on a Zeiss
LSM 510 Meta confocal microscope and densitometric analysis performed using ImageJ.
Two-photon multicellular Ca2+ imaging in the pituitary
Ca2+ imaging was performed on pituitary slices from lactating mice (day 10) expressing DsRed under the control of the prolactin
promoter as described previously (Hodson et al., 2012). Briefly, pituitaries were embedded in low melting point agarose (Invitrogen),
before preparing slices (150 mm) using a vibrating microtome (Campden Instruments). Slices were then loaded for 1 h with 20 mM
Fura-2 LR (TEFLabs) supplemented with pluronic acid (0.005%; Invitrogen). Multicellular Ca2+ imaging was performed using
a TriM Scope (LaVision BioTec) coupled to an Olympus BX51 frame, 20x 0.95 NA water-dipping objective (Olympus) andCell Reports 26, 1787–1799.e1–e5, February 12, 2019 e4
femtosecond-pulsed near-infrared laser (Coherent Chameleon) to produce two-photon excitation at l = 780 nm (Fura-2) and
l = 970 nm (DsRed). Emitted signals were detected at l = 525 ± 50 nm (Fura-2) and l = 593 ± 40 nm (DsRed) using a 14-bit,
512 3 512 pixel back-illuminated EM-CCD camera (Andor). Slices were perfused at 36C in a buffer containing 125 mM NaCl,
2.5 mM KCl, 1.25 mM NaH2PO4, 26 mM, NaHCO3, 12 mM glucose, 2 mM CaCl2 and 1 mM MgCl2 with met-enkephalin (500 nM)
added at the indicated time. A region of interest (ROI) was used to extract the intensity-over-time from Fura-2 loaded DsRed-positive
cells (i.e., lactotrophs). Cells were manually triaged and only those responding to treatment considered for further analysis (33.9 ±
2.3%; 327/957 cells analyzed from 7 slices). Ca2+-spiking frequency was measured in the responsive subpopulation using the
Short-Time Fourier Transform and component frequencies plotted as a function of their power for each independent recording using
0.005 Hz bins to produce a power spectrum. Significance was determined for the frequency with the greatest power before, during
and after treatment. All analysis was performed using custom scripts in R (R-Project) and results considered significant at p < 0.05.
QUANTIFICATION AND STATISTICAL ANALYSIS
All experiments were conducted on female mice. Unless otherwise stated, statistical analysis was performed using PRISM software
(GraphPad). Individual tests and n values are reported in the Results and in the relevant figure legends. All data are presented as
mean ±SEMper section. In all statistical tests, a value of p < 0.05 was accepted as significant. The number of TH andmet-enkephalin
immunoreactive cells in diestrus, late pregnant and lactating mice in Figure 1 was compared by one-way ANOVA followed by a
Tukey’s multiple comparison test with 4 to 5 animals per group. A one-way ANOVA was similarly used to compare levels of Th
mRNA and Penk mRNA expression between these three groups. In Figure 1 the level co-expression of TH and met-enkephalin
expression during diestrus and lactation were compared using an unpaired Student’s t test with 3 to 4 animals per group. In Figure 2
the effect of altering prolactin levels on the number of cells expressing met-enkephalin was compared using one-way ANOVA
followed by a Tukey’s multiple comparison test with 5 to 8 animals per group. The number of PenkmRNA positive neurons between
diestrous and lactating groups (Figure 2) was compared using unpaired Student’s t test with 4 to 6 animals per group. The effect of
prolactin after pup withdrawal on the number of PenkmRNA expressing cells was compared using unpaired Student’s t test with 4 to
6 animals per group. In Figure 3 the effect of prolactin receptor deletion on the number of cells expressing met-enkephalin (3 animals
per group) and the number of PenkmRNA positive cells (5 to 6 animals per group) was compared using two-way ANOVA followed by
a Tukey’smultiple comparison test with 3 animals per group. A two-way ANOVA, followed by a Tukey’smultiple comparison test, was
also used to compared the number of TH immunoreactive cells expressing pSTAT5 or pERK1/2, (Figure 4) with 3 to 6 animals per
group. In Figure 5 an unpaired Student’s t test was used to compare the relative level of met-enkephalin immunoreactivity in the
median eminence and the relative levels of phosphorylated TH measure by western blot. The data obtained from Ca2+ imaging in
Figure 6 was analyzed using custom scripts in R (R-Project).e5 Cell Reports 26, 1787–1799.e1–e5, February 12, 2019
